reference/12253724

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12253724

Outgoing Links

Predicate	Object
contentType	Controlled Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1089
issn	1029-2403 1042-8194
issueIdentifier	6
pageRange	1084-1089
publicationName	Leukemia & Lymphoma
startingPage	1084
bibliographicCitation	Hayashi Y, Nakamae H, Katayama T, Nakane T, Koh H, Nakamae M, Hirose A, Hagihara K, Terada Y, Nakao Y, Hino M. Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib. Leuk Lymphoma. 2012 Jun;53(6):1084–9. doi: 10.3109/10428194.2011.647017. PMID: 22211798.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4391065e1667633efcef5865bcd2ede http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8cb068805f204fe4bf7d2c9fefdd8e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84f09356b1a3053b38c623f24f7a15fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc4f52411e8ac803622aa23069a160cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4122853d25e255d0b2f14e34495004e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09e0930e48773d8ad2cb4c7cb4ece373 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50e3d9b9f6625e9de91f2db3eff349e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e48e06d1f3e68fe746166cd0ee48f310 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74ea2c48de29fdeb01536f790a5d4ea4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_117031c97140b05fffdf9a5f85a80eec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cd31f6f0ea7624e20a85cda32560fd4
date	2012-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3109/10428194.2011.647017 https://pubmed.ncbi.nlm.nih.gov/22211798
isPartOf	https://portal.issn.org/resource/ISSN/1029-2403 https://portal.issn.org/resource/ISSN/1042-8194 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2306
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib
discusses	http://id.nlm.nih.gov/mesh/M0482811 http://id.nlm.nih.gov/mesh/M0028294 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0024747 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D015464Q000276 http://id.nlm.nih.gov/mesh/D013844Q000627 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D010879Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D016131Q000502 http://id.nlm.nih.gov/mesh/D015464Q000097 http://id.nlm.nih.gov/mesh/D016207Q000378 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016207Q000097 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D016131Q000378 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D020014 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016131Q000187 http://id.nlm.nih.gov/mesh/D018925Q000378 http://id.nlm.nih.gov/mesh/D016131Q000276 http://id.nlm.nih.gov/mesh/D018925Q000097 http://id.nlm.nih.gov/mesh/D016130
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5c647247cf24a968b74ef2791c1bfa48 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c2a159e809d6704ac0fe2882a7fe64a1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_375c17477d468e8296a40307695528e6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e3868537116144d95299a08a96dd9ccc http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7387 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ef7041823e4fe98a3819558023bddc29 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d2a6d33ebbdffb2469b199f83c3ab1b1

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103

Total number of triples: 88.